Literature DB >> 15233320

Prevalence of HHV-8 infection in Albanian adults and association with HBV and HCV.

Nicola Schinaia1, Yllka Kodra, Loredana Sarmati, Massimo Andreoni, Silva Bino, Shpetim Qyra, Giovanni Rezza.   

Abstract

To estimate the prevalence of human herpesvirus type 8 (HHV-8) in Albania and its correlation with HBV and HCV, we tested 196 serum samples collected from apparently healthy adults (i.e., 154 women and 42 men). We found 20% anti-HHV-8 antibodies, about 10% HbsAg-positive, and 67% anti-HBc antibodies; anti-HCV antibody prevalence was 3%. It remains to be determined whether HHV-8 infection and HCV infection have common modes of transmission.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15233320     DOI： 10.1023/b:ejep.0000027358.38997.66

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


  16 in total

Review 1.  An overview of classic Kaposi's sarcoma in Greece.

Authors:  J D Stratigos; A C Katoulis; N G Stavrianeas
Journal:  Adv Exp Med Biol       Date:  1999       Impact factor: 2.622

2.  Prevalence and distribution of HHV-8 in different subpopulations, with and without HIV infection, in Spain.

Authors:  G Gambús; D Bourboulia; A Esteve; R Lahoz; C Rodriguez; F Bolao; G Sirera; R Muga; J del Romero; C Boshoff; D Whitby; J Casabona
Journal:  AIDS       Date:  2001-06-15       Impact factor: 4.177

3.  HBV, HCV and HDV infections in Albanian refugees in Southern Italy (Apulia region).

Authors:  M Chironna; C Germinario; P L Lopalco; M Quarto; S Barbuti
Journal:  Epidemiol Infect       Date:  2000-08       Impact factor: 2.451

4.  Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays.

Authors:  O Schatz; P Monini; R Bugarini; F Neipel; T F Schulz; M Andreoni; P Erb; M Eggers; J Haas; S Buttò; M Lukwiya; J R Bogner; S Yaguboglu; J Sheldon; L Sarmati; F D Goebel; R Hintermaier; G Enders; N Regamey; M Wernli; M Stürzl; G Rezza; B Ensoli
Journal:  J Med Virol       Date:  2001-09       Impact factor: 2.327

5.  Seroprevalence of Kaposi's sarcoma-associated herpesvirus in healthy adults in Israel.

Authors:  J Iscovich; A Fischbein; J Fisher-Fischbein; L S Freedman; S M Eng; P Boffetta; A Vudovich; C Glasman; R Goldschmidt; M Livingston; B Heger-Maslansky; P Brennan; P S Moore
Journal:  Anticancer Res       Date:  2000 May-Jun       Impact factor: 2.480

6.  High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: evidence of nonsexual transmission.

Authors:  M Andreoni; G El-Sawaf; G Rezza; B Ensoli; E Nicastri; L Ventura; L Ercoli; L Sarmati; G Rocchi
Journal:  J Natl Cancer Inst       Date:  1999-03-03       Impact factor: 13.506

7.  Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases.

Authors:  G Rezza; M Andreoni; M Dorrucci; P Pezzotti; P Monini; R Zerboni; B Salassa; V Colangeli; L Sarmati; E Nicastri; M Barbanera; R Pristerà; F Aiuti; L Ortona; B Ensoli
Journal:  J Natl Cancer Inst       Date:  1999-09-01       Impact factor: 13.506

8.  Sexual transmission and the natural history of human herpesvirus 8 infection.

Authors:  J N Martin; D E Ganem; D H Osmond; K A Page-Shafer; D Macrae; D H Kedes
Journal:  N Engl J Med       Date:  1998-04-02       Impact factor: 91.245

9.  Prevalence of hepatitis virus infections in Albanian refugees.

Authors:  T Santantonio; S Lo Caputo; C Germinario; S Squarcione; D Greco; V Laddago; G Pastore
Journal:  Eur J Epidemiol       Date:  1993-09       Impact factor: 8.082

10.  Prevalence of viral markers among refugees from southern Albania: increased incidence of infection with hepatitis A, B and D viruses.

Authors:  G N Dalekos; E Zervou; F Karabini; E V Tsianos
Journal:  Eur J Gastroenterol Hepatol       Date:  1995-06       Impact factor: 2.566
View more
  1 in total

Review 1.  Disseminated Kaposi sarcoma following COVID-19 in a 61-year-old Albanian immunocompetent man: a case report and review of the literature.

Authors:  Giulia Gardini; Silvia Odolini; Giovanni Moioli; Dorothea Angela Papalia; Vittorio Ferrari; Alberto Matteelli; Silvio Caligaris
Journal:  Eur J Med Res       Date:  2021-12-20       Impact factor: 2.175
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.